[1] Kelly KR, Ecsedy J, Mahalingam D, et al. Targeting aurora kinases in cancer treatment[J]. Curr Drug Targets, 2011,12(14):2067-2078. [2] Hood FE, Royle SJ. Pulling it together: The mitotic function of TACC3[J]. Bioarchitecture, 2011,1(3):105-109. [3] Do TV, Xiao F, Bickel L E, et al. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion[J]. Oncogene, 2014,33(5):539-549. [4] Mehra R, Serebriiskii IG, Burtness B, et al. Aurora kinases in head and neck cancer[J]. Lancet Oncol, 2013,14(10):e425-e435. [5] 张潍, 王建, 辛晓燕, 等. Aurora-A过表达与宫颈癌进展及预后的关系[J]. 中国实用妇科与产科杂志, 2012,28(4):280-283. [6] Mahdipour M, Leitoguinho AR, Zacarias SR, et al. TACC3 is important for correct progression of meiosis in bovine oocytes[J]. PLoS One, 2015,10(7):e132591. [7] Hood FE, Williams SJ, Burgess SG, et al. Coordination of adjacent domains mediates TACC3-ch-TOG-clathrin assembly and mitotic spindle binding[J]. J Cell Biol, 2013,202(3):463-478. [8] Umene K, Yanokura M, Banno K, et al. Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer[J]. Int J Oncol, 2015,46(4):1498-1506. [9] de Martino M, Shariat SF, Hofbauer SL, et al. Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer[J]. World J Urol, 2015,33(1):105-110. [10] 刘恩伊, 钟美佐, 刘巍, 等. 青年胃癌的发病及临床病理特点[J]. 实用预防医学, 2010,17(3):544-546.
2016, Vol. 23 
